Pediatric IBD Patients Treated With Infliximab and Proactive Drug Monitoring Benefit From Early Concomitant Immunomodulatory Therapy: A Retrospective Analysis of a 10-Year Real-Life Cohort.

Hoelz, Hannes; Bragagna, Lena; Litwin, Anna; Koletzko, Sibylle; Le Thi, Thu Giang; Schwerd, Tobias

Hoelz, Hannes; Bragagna, Lena; Litwin, Anna; Koletzko, Sibylle; Le Thi, Thu Giang; Schwerd, Tobias.

Affiliation

Hoelz H; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Germany.
Bragagna L; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Germany.
Litwin A; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Germany.
Koletzko S; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Germany.
Le Thi TG; Department of Pediatrics, Gastroenterology and Nutrition, School of Medicine Collegium Medicum University of Warmia and Mazury, Olsztyn, Poland.
Schwerd T; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, Germany.

Inflamm Bowel Dis ; 2023 Nov 27.

Article de En | MEDLINE | ID: mdl-38011813

Mots clés

Crohn's disease; children; infliximab; proactive therapeutic drug monitoring; ulcerative colitis

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Langue: En Journal: Inflamm Bowel Dis Sujet du journal: GASTROENTEROLOGIA Année: 2023 Type de document: Article Pays d'affiliation: Allemagne Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google